128 results found | searching for "organ"

• 
• The Intravenous Immunoglobulin Market continues to grow at a remarkable pace, with its valuation at USD 14.02 billion in 2024 and projected to reach USD 25.39 billion by 2032. This growth trajectory represents a compound annual growth rate (CAGR) of 7.72% between 2025 and 2032. The market’s expansion is closely tied to increasing cases of autoimmune and neurological disorders, broader applications of IVIG in off-label therapies, and the global surge in demand for life-saving plasma-derived products. Growing Need for Immunoglobulin Therapies Intravenous immunoglobulin (IVIG) has become a cornerstone therapy in treating a wide array of conditions, from primary and secondary immunodeficiency to autoimmune and neurological disorders. The growing prevalence of conditions such as chronic inflammatory demyelinating polyneuropathy (CIDP), myasthenia gravis, Guillain-Barré syndrome, and immune thrombocytopenia is significantly driving demand. Beyond these, IVIG has gained traction in off-label applications, including its role in treating severe infections and complications from organ transplants. With patients worldwide seeking reliable immune-boosting therapies, manufacturers are scaling up production and investing in advanced purification technologies to ensure safety and effectiveness. Read More: https://www.snsinsider.com/reports/intravenous-immunoglobulin-market-7356

  by HealthInsider,  Health 

  0 reply
• 
• Stem Cell Therapy for Organ Diseases Visit us https://bit.ly/4gtcueg

  by globalregenex,  Health 

  0 reply
• 
• Best Professional Massage Reflexology New York Experience expert massage and reflexology at Ming Qi, one of New York’s most trusted wellness centers. Our therapists use precise techniques to relieve muscle tension, reduce stress, and improve circulation. Reflexology focuses on pressure points in the feet and hands to support internal organ function and balance the nervous system. Ideal for total relaxation and ongoing wellness, our massage services are tailored to your specific health needs, offering relief and rejuvenation in every session. Read more: http://www.gomingqi.com/massage-house/

  by gomingqi,  General Health Care 

  0 reply
• 
• Moxibustion Youth Longevity Experience the age-defying benefits of moxibustion for youth and longevity at Ming Qi. This ancient therapy stimulates vital energy, boosts immunity, and enhances organ function—supporting graceful aging from within. Regular sessions improve circulation, reduce fatigue, and keep your body's systems in harmony. Reclaim your vitality naturally and maintain your wellness for years to come Read More: https://blague-courte.com/where-can-you-find-truly-healing-massage-therapy-in-new-york

  by gomingqi,  Health 

  0 reply
• 
• CBLMF™ blood-brain barrier model recreates the in vivo microenvironment by replicating a histological slice of brain tissue cells. The model is able to do this by communicating with endothelial cells across the blood-brain barrier (BBB). As a result, shear-induced endothelial cell tight junctions are easily achieved in the model using physiological fluid flow. https://microfluidics.creative-biolabs.com/cblmf-3d-tissue-and-organ-on-chip-models.htm

  by cailynnjohnson,  Biology 

  0 reply
• 
• Best medical tourism company in India GoMedii is a top-rated medical tourism company in India, offering affordable, high-quality healthcare solutions for international patients. Specializing in a wide range of treatments like cancer care, organ transplants, cosmetic surgery, and more, GoMedii connects patients with leading hospitals and expert doctors. https://gomedii.com/medical/tourism-company-in-india?lang=en

  by manishwts,  Health 

  0 reply
• 
• Dr. A. S. SOIN Hepatobiliary and Liver Transplant Surgeon Dr. A S Soin is known all over the world for his pioneering work in developing liver transplantation in India. Between 2001 and mid-2010, he created a large liver transplant center at Sir Gangaram Hospital. However, in June 2010, he relocated with his entire staff to Medanta-The Medicity in Gurgaon (Delhi-NCR). Medanta, with 925 beds (and soon to be 1500), is one of the country's largest and most modern tertiary care hospitals, and Dr. Soin has established a 150-bed (including 36 Liver ICU beds) dedicated Liver Treatment facility, which performs 250 liver transplants and hundreds of complex liver and biliary tract surgeries each year. In his 21-year career as a Liver Transplant Surgeon and Hepatobiliary Surgeon, he has conducted over 1500 liver transplants and over 12000 more difficult liver, gall bladder, and bile duct procedures. Dr. Soin serves on the committees of all major national and international societies, as well as the National Advisory Board for Liver Transplantation. He is a regular faculty member and speaker (often the only one from India) at major international liver transplantation conferences, including ILTS, AASLD, APDW, IHPBA, IASGO, APASL, Asian Living Donor Liver Transplant Group, Asia Pacific Organ Transplant Forum, and so on. Visit- https://www.livertransplantindia.com/liver-transplant-surgeon/

  by ibpaulsmith,  Health 

  0 reply
• 
• Dive into the transformative world of primary cell culture and discover its pivotal role in modern research. From ethical practices to human biology-relevant responses and personalized therapeutics, primary cells offer unparalleled insights. Learn how these cells are revolutionizing drug testing, disease modeling, and advancements in organ-on-chip technology. Explore our blog for a deeper understanding of primary cell culture's immense potential. https://medium.com/@kosheekaaa/exploring-the-advantages-and-uses-of-primary-cell-culture-in-modern-research-2179d441729e

  by kosheekaa,  Alternative Medicine 

  0 reply
• 
• Driving Regenerative Medicine Advances: Tissue Engineering Market to Reach $8.9 Billion by 2028 https://www.marketsandmarkets.com/Market-Reports/tissue-engineering-market-34135173.html The tissue engineering market is expected to reach USD 8.9 billion by 2028 from an estimated USD 4.4 billion in 2023, at a CAGR of 15.3% during the forecast period. The growth is attributed to numerous factors including increasing incidences of road accidents, rising demand for regenerative medicines for the treatment of chronic diseases, and growing technological advancements in the biopharmaceutical sector. In addition, increasing research activities in the field of tissue engineering is promoting the growth of the tissue engineering market. Download a PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=34135173 3D bioprinting is an innovative technology in tissue engineering, that enables the precise fabrication of intricate tissue structures, vital for regenerative medicine and drug testing. Its development is primarily propelled by continual technological advancements, including improved bio inks and printing techniques, coupled with the critical need to address organ shortages and revolutionize medical treatments. Material innovation also plays a pivotal role, in fostering the creation of biocompatible substances essential for enhancing the viability and functionality of bio-printed tissues. Additionally, collaborative research efforts among multidisciplinary fields drive progress, promising transformative solutions in healthcare. Based on product type, the tissue engineering market has been segmented into scaffolds, tissue grafts, and other products. In 2022, scaffolds accounted for the largest market share. Scaffold-driven tissue engineering hinges on biocompatibility, mechanical robustness, and optimal pore structure for cell infiltration and nutrient exchange. Integration of bioactive cues and vascular-like properties also fuels advancements, crucial for crafting functional and viable engineered tissues. These driving factors collectively shape scaffold design, influencing their efficacy in tissue engineering applications. Based on material, the global tissue engineering market is segmented into synthetic materials and biologically derived materials. Synthetic material accounted for major market share of the tissue engineering market in 2022. The large share of this segment can be attributed to the cost effectiveness of the synthetic products as compared to the biologically derived products. In addition, increasing demand for advanced and cost-effective tissue engineering solutions is propelling the growth of the synthetic material segment in the tissue engineering market. Based on application, the tissue engineering market is segmented into orthopedics & musculoskeletal disorders, dermatology & wound care, dental disorders, cardiovascular diseases, and others. In 2022, orthopedics & musculoskeletal disorders accounted for the largest share of the global tissue engineering market. The large share of the segment can primarily be attributed to rising demand for high quality tissue engineering products for the repair and reconstruction of damaged tissues or organs. Additionally, increasing incidences of road accidents are promoting the adoption of tissue engineering products for tissue reconstruction. Based on end users, the tissue engineering market has been segmented into hospitals, specialty centers and clinics, and ambulatory surgical centers. Hospitals accounted for the largest market share of the tissue engineering market. The large share of the segment can primarily be attributed to the increasing demand for advanced regeneration solutions for the reconstruction and regeneration of tissues. Additionally, the increasing rate of chronic and degenerative diseases is driving the demand for hospitals. The key regional markets for the global tissue engineering market are Europe, North America, Asia Pacific, Latin America, and the Middle East & Africa. In 2022, North America accounted for the largest share of the market. The large share of this region can be attributed to the growing technological developments in the healthcare sector and rising research activities for the advancements of the tissue engineering field. However, most of the growth in the market is expected from emerging countries across Asia Pacific. During the forecast period, the Asia Pacific is expected to grow with the fastest CAGR due to the increasing adoption of innovative technologies for the treatment of chronic and degenerative diseases. Key players in the global tissue engineering market include Organogenesis (US), AbbVie Inc. (US), Baxter (US), BD (US), B. Braun (Germany), TEIJIN Limited (Japan), Institut Straumann AG (Switzerland), Integra Lifesciences (US), Johnson & Johnson Services, Inc. (US), Medtronic (Ireland), NuVasive, Inc. (US), Stryker (US), Terumo Corporation (Japan), W. L. Gore & Associates Inc. (US), Zimmer Biomet (US), Smith & Nephew plc (UK), MIMEDX Group, Inc. (US), BioTissue (US), CollPlant Biotechnologies Ltd. (Israel), Sumitomo Pharma Co., Ltd. (Japan), Matricel GmbH (Germany), Mallinckrodt (US), Regrow Biosciences Pvt Ltd (India), Vericel Corporation (US), Tecnoss S.R.L. (Italy), Tegoscience (South Korea), and Tissue Regenix (UK). Recent Developments of Tissue Engineering Industry In September 2023, MIMEDX Group Inc. launched EPIEFFECT to broaden its advanced wound care product portfolio. EPIEFFECT is a lyophilized human placental-based allograft consisting of amnion and chorion membranes. In July 2023, Teijin Limited launched SYNFOLIUM, a cardiovascular surgical patch and received manufacturing and marketing approval in Japan. The cardiovascular surgical patch is used for the surgical treatment of congenital heart disease (CHD). In July 2021, Integra Lifesciences introduced SurgiMend, a collagen matrix. The product is used for soft tissue repair and reconstruction. In May 2020, AbbVie Inc. (US) acquired Allergan plc (Ireland) to expand the product portfolio in therapeutics categories. Allergan plc provides new growth opportunities to AbbVie Inc. in neuroscience with Vraylar, Botox therapeutics, and global aesthetics business.

  by Healthcare_medical,  Health 

  0 reply
• 
• Medelink's Organ-on-Chip: Advanced Research Tool Medelink's organ-on-chip technology mimics human organs on a small chip. These devices recreate organ functions and structures, allowing researchers to study diseases and test drugs in a realistic environment. This innovative technology helps develop effective treatments by providing accurate models of human organs, revolutionizing biomedical research and advancing personalized medicine. Medelink’s organ-on-chip offers a powerful tool for cutting-edge scientific exploration. For more information - https://medelink.ca/research-devices/relego-4d-organ-on-chip-platform/

  by Annaengerritch,  Canada 

  0 reply